MIST
Milestone Pharmaceuticals Inc
0.8097$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | +0.0% | +0.0% | -100.0% | – | – | +133.3% | -71.4% | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | -84.6% | +134.9% | – | |
| – | – | – | – | – | – | – | – | – | – | -4.6% | -98.9% | -74.4% | +40,887.0% | +3.2% | -97.0% | -92.1% | +4.3% | +40,843.4% | -95.9% | -95.6% | +33.3% | 0.0% | +2,116.8% | +0.0% | -95.1% | -3.8% | +2,168.0% | -95.2% | +3.7% | -10.7% | +36.0% | +105.9% | -54.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -164.9% | – | – | – | – | +133.3% | -71.4% | -102.4% | – | – | – | – | – | – | – | – | – | – | -89.1% | +213.7% | – | |
| – | -17.5% | +53.3% | +86.6% | +6.4% | +35.6% | -9.3% | +48.2% | -16.1% | -26.8% | -2.0% | -32.3% | +49.1% | +10.7% | +4.4% | +9.8% | -19.6% | +21.5% | -7.8% | +9.0% | -4.3% | -15.9% | -22.0% | -19.1% | -33.0% | -22.6% | +40.8% | -0.6% | +26.3% | -26.3% | +9.4% | +37.6% | -39.1% | +4.4% | – | |
| – | +70.8% | -13.9% | +88.5% | -19.6% | +67.6% | +28.2% | +8.3% | +18.6% | +9.4% | -0.1% | -43.3% | +57.3% | +14.6% | -1.9% | +27.9% | -3.8% | +7.5% | +3.0% | -9.9% | +7.0% | +14.3% | -4.9% | -20.3% | +17.3% | +27.6% | -25.8% | +6.9% | +29.1% | -27.2% | -13.9% | +57.0% | -5.1% | +369.5% | – | |
| – | -13.6% | +57.4% | +74.7% | +8.1% | +31.1% | -4.2% | +37.6% | -11.3% | -73.2% | -14.0% | +124.8% | +45.2% | +13.5% | -68.2% | +268.0% | -15.9% | +19.6% | -1.6% | +4.4% | -4.4% | -0.4% | -6.5% | -13.1% | -21.5% | -7.8% | -0.5% | +28.4% | +66.2% | -38.9% | -5.2% | +58.3% | +27.3% | +9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,104.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +34.4% | +22.2% | – | – | -69.6% | -29.4% | – | – | -27.5% | – | – | +17.6% | +295.0% | +200.0% | +6,531.9% | -99.9% | +2,384.8% | +2.6% | +1.9% | +1.8% | +1.7% | +1.8% | +1.8% | +1.7% | +1.7% | +1.7% | +1.9% | +319.8% | +14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,947.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -87.5% | – | – | -60.7% | -118.2% | – | – | – | – | – | +0.0% | -635.3% | – | – | – | – | – | – | – | – | – | -7.7% | -106.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,947.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,890.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.